Showing 381 - 400 results of 64,164 for search '(( 5 ((ht decrease) OR (step decrease)) ) OR ( 5 ((a decrease) OR (nn decrease)) ))', query time: 0.94s Refine Results
  1. 381
  2. 382
  3. 383
  4. 384
  5. 385
  6. 386
  7. 387

    Data_Sheet_1_Secondhand Smoke Decreased Excitability and Altered Action Potential Characteristics of Cardiac Vagal Neurons in Mice.PDF by Junqing Sun (4688998)

    Published 2021
    “…Perfusion with apamin (20 nM) magnified these SHS-induced effects, suggesting reduced SK channel activity may serve to minimize the SHS-induced decreases in CVNs excitability. Medium afterhyperpolarization (a measurement of SK channel activity) was smaller in the SHS group, further supporting a lower SK channel activity. …”
  8. 388
  9. 389

    Changes in the SF change rate every 5 s in Experiment 1. by Hiroaki Furukawa (14341649)

    Published 2023
    “…Compared to no footsteps condition (NF), the step frequency seems to decrease in the +5 bpm (A) and -5 bpm (B) footsteps condition but there were no significant differences between these conditions.…”
  10. 390
  11. 391

    Temporal profiles of the key BO-NN features. by Julia Berezutskaya (9080269)

    Published 2020
    “…Right plot show the gradual decrease in the TM tuning for the features highlighted in <b>c</b> as well as the gradual increase in the temporal response profile (i.e. optimal shifts for the prediction of the key BO-NN features using Praat features shown in <b>a</b>). …”
  12. 392

    Image1_The 5HT4R agonist velusetrag efficacy on neuropathic chronic intestinal pseudo-obstruction in PrP-SCA7-92Q transgenic mice.JPEG by Yongqiang Liu (651861)

    Published 2024
    “…Herein, we report the characterization of the PrP-SCA7-92Q transgenic (Tg) line as a valuable CIPO mouse model and investigated the tolerability and efficacy of the 5-hydroxytryptamine type-4 receptor (5HT4R) agonist velusetrag as a promising pharmacological treatment for CIPO.…”
  13. 393

    Image3_The 5HT4R agonist velusetrag efficacy on neuropathic chronic intestinal pseudo-obstruction in PrP-SCA7-92Q transgenic mice.JPEG by Yongqiang Liu (651861)

    Published 2024
    “…Herein, we report the characterization of the PrP-SCA7-92Q transgenic (Tg) line as a valuable CIPO mouse model and investigated the tolerability and efficacy of the 5-hydroxytryptamine type-4 receptor (5HT4R) agonist velusetrag as a promising pharmacological treatment for CIPO.…”
  14. 394

    Image2_The 5HT4R agonist velusetrag efficacy on neuropathic chronic intestinal pseudo-obstruction in PrP-SCA7-92Q transgenic mice.JPEG by Yongqiang Liu (651861)

    Published 2024
    “…Herein, we report the characterization of the PrP-SCA7-92Q transgenic (Tg) line as a valuable CIPO mouse model and investigated the tolerability and efficacy of the 5-hydroxytryptamine type-4 receptor (5HT4R) agonist velusetrag as a promising pharmacological treatment for CIPO.…”
  15. 395

    DataSheet1_Lorcaserin Inhibit Glucose-Stimulated Insulin Secretion and Calcium Influx in Murine Pancreatic Islets.docx by Muhan Jing (11651452)

    Published 2021
    “…Lorcaserin can restrain patients’ appetite and improve insulin sensitivity and hyperinsulinemia mainly through activating 5-HT<sub>2C</sub>R in the hypothalamus. It is known that the mCPP, a kind of 5-HT<sub>2C</sub>R agonist, decreases plasma insulin concentration in mice and previous research in our laboratory found that mCPP inhibited glucose-stimulated insulin secretion (GSIS) by activating 5-HT<sub>2C</sub>R on the β cells. …”
  16. 396
  17. 397
  18. 398
  19. 399

    Preliminary experiment. by Takahiro Tanaka (159434)

    Published 2019
    “…However, grip strength gradually declined from 6 weeks, and showed a significant difference at 7 weeks after surgery (P < 0.0001: two-way ANOVA) After that, the strength continued to decrease gradually, reaching approximately 10.5 N at 26 weeks postoperatively.…”
  20. 400